Aimtron Electronics Limited reported its audited consolidated financial results for FY2026. The company achieved a consolidated net profit of ₹45.97 Crore on a total income of ₹303.51 Crore. The board approved these results in their meeting held on April 27, 2026.
Kotyark Industries Limited reported its standalone annual total income of ₹296.54 Crore for FY26. The board recommended a final dividend of ₹5 per equity share (50% of face value). The company also successfully migrated from the NSE SME platform to the NSE and BSE main boards during the period.
The Phoenix Mills Limited reported its audited standalone and consolidated financial results for FY26. The Board recommended a final dividend of Rs. 2.50 (125%) per equity share of face value Rs. 2 each. Additionally, N. A. Shah Associates LLP was re-appointed as internal auditors for FY27.
International Travel House Ltd reported a total income of ₹237.64 Crore for the financial year ended March 31, 2026. The Board recommended a final dividend of ₹5.50 per share. Net profit for the period stood at ₹18.48 Crore, reflecting steady operational performance in travel-related services.
Websol Energy System Ltd reported audited financial results for FY26 and recommended a final dividend of Re. 0.25 per share (₹10.85 Crore aggregate). The board also re-appointed Mr. Sohan Lal Agarwal as Managing Director for three years and appointed RSM Astute Consulting as Internal Auditor.
Unicommerce eSolutions Ltd reported consolidated annual financial results for FY2026, with a net profit of ₹28.78 Crore. Revenue from operations reached ₹204.34 Crore. The Board approved the results with an unmodified audit opinion from Price Waterhouse Chartered Accountants LLP.
Piccadily Sugar and Allied Industries Financial Results
Piccadily Sugar & Allied Industries Ltd reported a total income of ₹6.82 Crore for the financial year ended March 31, 2026. The board also approved the resignation of statutory auditors Jain & Associates due to personal reasons and recommended the appointment of Rattan Kaur & Associates to fill the casual vacancy.
Aptus Pharma Limited reported a revenue of ₹46.57 Crore and a net profit of ₹4.62 Crore for the financial year ended March 31, 2026. The Board also fixed May 12, 2026, as the record date for a 3:2 bonus share issue, following shareholder approval via postal ballot.
Iykot Hitech Toolroom Ltd reported standalone financial results for FY26, alongside board approval for director appointments and resignations. The company also confirmed a NIL statement of deviation for its ₹4.74 Crore Rights Issue proceeds. Management changes include the resignation of the Company Secretary and Whole Time Director.
Jagsonpal Pharmaceuticals reported FY26 total income of ₹299.22 Crore and Net Profit of ₹43.08 Crore. The Board recommended a dividend of ₹4 (200%) per equity share. Additionally, a buy-back of up to 16,00,000 equity shares at ₹250 per share was previously approved, totaling ₹40 Crore.
Aanchal Ispat Ltd reported audited financial results for FY26, posting a total income of ₹101.29 Crore and a net profit of ₹2.02 Crore. The Board also approved raising up to ₹10 Crore via Qualified Institutions Placement (QIP) and scheduled an EGM for May 23, 2026, to seek shareholder approval.
Mahip Industries Ltd reported audited financial results for the year ended March 31, 2026. The company recorded total income of ₹9.11 Crore and a net profit of ₹2.80 Crore for the fiscal year. The auditors issued a qualified opinion regarding balance confirmations, loan contraventions, and fixed asset revaluation.
Punjab & Sind Bank approved its audited financial results for FY 2025-26, reporting a net profit of ₹1,321.93 Crore. The Board recommended a dividend of ₹0.39 per equity share (3.90%), subject to shareholder approval. The bank's Provision Coverage Ratio improved to 90.91%.
AGI Greenpac Ltd reported audited consolidated revenue of ₹2,665.32 Crore and profit of ₹351.66 Crore for FY26. The Board recommended a final dividend of 350% (₹7 per share). Key leadership appointments include Mr. Ram Babu Kabra as Director and Mr. Abhijeet Srivastava as VP - CMD Office.
Astec LifeSciences Limited reported its audited financial results for the quarter and year ended March 31, 2026. The Board also approved the appointment of new directors including Mr. Vishal Sharma and Mr. Burjis Godrej as Non-Executive Directors, and fixed July 31, 2026, as the date for its 32nd Annual General Meeting.